Progression-free survival ratio as end point for phase II trials in advanced solid tumors
J Clin Oncol
.
2011 May 20;29(15):e451-2; author reply e453.
doi: 10.1200/JCO.2010.34.0380.
Epub 2011 Apr 4.
Authors
Marc Buyse
,
Emmanuel Quinaux
,
Alain Hendlisz
,
Vassilis Golfinopoulos
,
Christophe Tournigand
,
Rosemarie Mick
PMID:
21464417
DOI:
10.1200/JCO.2010.34.0380
No abstract available
Publication types
Comment
Letter
MeSH terms
Clinical Trials, Phase I as Topic / methods*
Disease-Free Survival*
Humans
Neoplasms / drug therapy*
Neoplasms / pathology